An unsolicited bid can quickly change the operating environment for a public company. Directors face heightened market scrutiny, accelerated disclosure demands and consequential decisions about value, timing and strategic direction.
Responding effectively requires more than a defensive tactic. It requires a disciplined process that protects optionality, supports accurate communication and gives the board sufficient time to evaluate the full range of available alternatives.
A white knight takeover offers one possible path. A friendly acquirer may improve price, certainty or strategic fit. But the label does not make the decision simple. The same rigor and independence still apply.
What Is a White Knight Takeover?
In corporate finance, a white knight is a friendly third-party buyer invited or supported by the target after an unsolicited bidder seeks control. The target still loses its independence if the transaction closes. The difference is that the board has an opportunity to negotiate value, structure, protections, and execution terms.
A hostile takeover generally involves an acquirer pursuing control without the target board’s approval. The bidder may launch a tender offer directly to shareholders, accumulate shares, seek board control through a proxy contest, or combine those approaches.
This is not about preserving management for its own sake.
It is about creating a credible alternative. Depending on applicable law and transaction circumstances, boards may be required to focus on maximizing shareholder value or otherwise fulfill applicable fiduciary duties.
Why Boards Consider the Strategy
When a hostile takeover attempt becomes public, the board should activate its response team and establish a controlled decision process. The immediate priorities are clear:
- Confirm the bidder’s ownership, financing, conditions, and intentions.
- Convene independent directors and identify conflicts.
- Retain qualified legal, financial, proxy, and communications advisors.
- Review the charter, bylaws, rights plan, debt covenants, and change-of-control provisions.
- Assess standalone value, the proposal, and other strategic alternatives.
- Establish disclosure controls and secure information-sharing protocols.
If the board seeks another bidder, it should focus on counterparties with strategic logic, financing capacity, regulatory credibility, and the ability to move at deal speed. A higher price may be less valuable if it depends on uncertain financing, extensive diligence, significant divestitures, or a prolonged approval process.
The white knight strategy must compare total value with execution risk. Consideration matters. So do financing, regulatory review, closing conditions, integration risk, and the buyer’s record of completing complex transactions.
White Knight Versus Other Knights
Contested M&A uses several informal labels:
- Black knight: The unsolicited bidder seeking control over the target board’s opposition.
- Gray knight: A third party that enters after the initial approach but may pursue its own interests on terms that are not clearly more favorable.
- Yellow knight: A bidder that begins aggressively but later abandons the hostile approach and proposes a negotiated combination.
- White squire: A friendly investor that acquires a significant minority position without purchasing the company outright.
These labels describe posture, not legal status. A friendly bidder may demand restrictive protections. An aggressor may improve its price and negotiate acceptable terms. Boards must evaluate substance, not labels.
Defensive Tools That Create Time and Leverage
A friendly sale is one option within a broader defense framework. Other tools can create time, improve leverage, or protect the board’s decision process:
- Shareholder rights plan: Often called a poison pill, this may dilute a bidder that crosses a specified ownership threshold without board approval, making further accumulation more expensive.
- White squire investment: A negotiated minority placement may introduce a supportive holder capable of blocking or complicating an unwanted transaction.
- Proxy response: The company may solicit support for incumbent directors or its strategic plan when the bidder seeks board control.
- Litigation or regulatory challenge: Counsel may challenge disclosure deficiencies, financing claims, antitrust issues, or other legal defects.
- Alternative transaction: A recapitalization, asset sale, repurchase, separation, or other strategic action may offer greater value, subject to fiduciary and legal review.
Defensive measures cannot be deployed solely to entrench leadership and should be evaluated under applicable fiduciary and legal standards. Every action requires a defensible basis, a proportionate response to the threat, and a clear connection to shareholder interests.
When a Minority Investment May Be Preferable
A minority investment may provide time or stability without selling the company. It may also complicate the unwanted bidder’s path to voting control.
Voting commitments, board representation, transfer restrictions, information rights, and exit rights can affect other shareholders and future flexibility. Stock-exchange approval rules may also apply.
Define the investor’s role, governance rights, and exit mechanism. A defensive placement can become a long-term constraint.
Building a Defensible Regulatory and Disclosure Process
Contested transactions create overlapping securities-law, governance, antitrust, exchange, and industry requirements. The company needs a disclosure process that moves quickly without sacrificing control.
An investor that acquires beneficial ownership of more than 5% of a covered class with control intent generally files Schedule 13D within five business days and reports material changes through amendments generally due within two business days. A bidder commencing a tender offer files Schedule TO. The target generally must state its position through Schedule 14D-9 within 10 business days after the tender offer begins. Proxy solicitations must comply with the federal proxy rules.
Disclosure obligations do not end with the initial response. Recommendations, negotiations, alternatives, conflicts, advisor analyses, and agreements can create filing or amendment requirements. The Allergan matter below shows the risk of public statements becoming inconsistent with material private developments.
Maintain a current fact base. Route statements through legal review. Coordinate filings, investor materials, and employee communications around the same approved narrative. Inconsistent disclosure can erode compliance and credibility.
Case Studies and Lessons for Modern Boards
Allergan, Valeant, and Actavis
In 2014, Valeant Pharmaceuticals and Pershing Square pursued Allergan through an unsolicited exchange offer and proxy campaign. Allergan rejected the proposal and later agreed to a friendly cash-and-stock acquisition by Actavis valued at approximately $66 billion, or $219 per Allergan share when announced.
The transaction shows how competition can change valuation. It also offers a warning: the SEC later brought an enforcement action concerning Allergan’s failure to update disclosures as alternative discussions became material.
Schering, Merck KGaA, and Bayer
In 2006, Merck KGaA announced an unsolicited offer for Schering. Bayer then agreed with Schering on a higher supported offer. The contest demonstrates the importance of price, strategic fit, speed, and competing share accumulations.
The lesson is not that every target should seek a competing buyer. It is that boards should prepare early, define their criteria, preserve competitive tension without sacrificing certainty, and document why the selected path serves shareholder interests.
A Practical Board Decision Framework
Before soliciting another bidder, directors should ask:
- Is the unsolicited proposal financially adequate and fully financed?
- Does the standalone plan offer credible superior value at an acceptable risk?
- Which parties have both strategic interest and execution capacity?
- Would a market check improve value or create unacceptable information leakage?
- What regulatory, financing, tax, and timing risks attach to each alternative?
- Are management incentives or relationships creating conflicts?
- What information can be shared, with whom, and under what protections?
Use a secure data room with role-based permissions, staged disclosure, audit trails, and clean-team procedures. Give the board comparisons showing price, certainty, closing probability, timing, and conditions.
Negotiating Beyond the Headline Price
Price matters, but the highest nominal offer is not always the strongest transaction. Boards should evaluate the complete value proposition: consideration, financing certainty, regulatory covenants, reverse termination fees, representations and warranties, closing conditions, employee retention, and treatment of equity awards.
Deal protections may include no-shop provisions, matching rights, termination fees, and voting commitments. Those provisions should preserve a defensible ability to consider superior proposals and must be assessed under applicable fiduciary standards.
Shareholder messaging should be factual and process-oriented. A useful core statement is: “The board is evaluating the proposal and available strategic alternatives with its independent advisors and will communicate further when appropriate. Shareholders do not need to take action at this time.” Tailor every communication to the facts and legal posture; avoid promises about outcome, timing, leadership retention, or value that the company cannot support.
Technology and Controls Designed for Deal Speed
Contested transactions generate intense diligence, reporting, and communication demands. Disconnected documents, email-based handoffs, and inconsistent access controls add risk at the moment teams can least afford it.
DFIN Venue provides a secure virtual data room for controlled diligence, permissioned access, document staging, monitoring, and collaboration. ActiveDisclosure supports coordinated SEC reporting and disclosure workflows, helping teams maintain control as facts, drafts, and filing requirements evolve.
Across these solutions, purpose-built technology is backed by DFIN’s transaction and regulatory expertise, including deal-document, proxy and filing support.
Move with Speed. Maintain Control.
A friendly bidder can create leverage and a credible alternative. It can also introduce valuation, regulatory, governance, and integration risks. Success still depends on judgment, secure diligence, accurate disclosure, and negotiation focused on shareholder value.
Boards that prepare their governance framework, response team, disclosure controls, and transaction technology before a bid emerges are better positioned to act under pressure. With the right process, expertise, and infrastructure, a contested situation becomes a structured evaluation of strategic alternatives, not a race dictated by the first bidder to go public.
